| Breakdown | TTM | Mar 2024 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.86B | 2.72B | 2.32B | 2.01B | 1.90B | 1.44B |
| Gross Profit | 444.30M | 408.80M | 295.70M | 276.80M | 265.70M | 186.50M |
| EBITDA | 308.60M | 280.70M | 220.00M | 199.00M | 185.50M | 118.30M |
| Net Income | 148.00M | 134.30M | 111.40M | 103.50M | 92.50M | 69.60M |
Balance Sheet | ||||||
| Total Assets | 1.72B | 1.53B | 1.26B | 1.14B | 1.04B | 717.90M |
| Cash, Cash Equivalents and Short-Term Investments | 10.30M | 5.90M | 20.40M | 200.00K | 39.90M | 20.50M |
| Total Debt | 413.90M | 178.30M | 121.70M | 106.20M | 131.40M | 14.20M |
| Total Liabilities | 693.00M | 543.30M | 421.50M | 373.60M | 355.00M | 183.00M |
| Stockholders Equity | 1.02B | 987.90M | 842.90M | 768.90M | 686.10M | 534.90M |
Cash Flow | ||||||
| Free Cash Flow | 27.70M | 78.70M | 64.10M | 64.70M | 109.00M | 8.50M |
| Operating Cash Flow | 206.70M | 216.30M | 149.20M | 158.40M | 180.90M | 87.70M |
| Investing Cash Flow | -228.90M | -160.40M | -83.80M | -130.90M | -81.80M | -81.00M |
| Financing Cash Flow | 23.80M | -77.00M | -45.30M | -66.30M | -81.60M | -6.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | £1.80B | 4.47 | 15.61% | 1.62% | 2.31% | 8.35% | |
78 Outperform | £2.79B | 8.36 | 14.71% | 2.06% | 6.96% | 28.47% | |
70 Outperform | £1.86B | 6.69 | 12.20% | 0.79% | 7.74% | 31.48% | |
69 Neutral | £12.56B | 7.89 | 8.44% | 2.98% | -2.16% | -24.87% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | £482.27M | 3.61 | 14.17% | 7.01% | 5.67% | 22.05% |